Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria

Area of Science:

• Microbiology
• Medicinal Chemistry
• Drug Discovery

Background:

• The rise of antibiotic resistance poses a significant public health threat, driving the need for novel antimicrobial strategies.
• Traditional drug development has largely overlooked membrane-binding properties, unlike natural biological pathway regulation.
• Vancomycin, a critical antibiotic, faces challenges from resistant bacterial strains.

Purpose of the Study:

• To rejuvenate the efficacy of the glycopeptide antibiotic vancomycin by developing a novel membrane-targeting strategy.
• To create a new class of lipoglycopeptides with enhanced activity against resistant bacteria.

Main Methods:

• Development of peptide libraries with positively charged electrostatic effector sequences.
• Ligation of these peptides to N-terminal lipophilic membrane-insertive elements.
• Conjugation of the modified peptides to vancomycin to create 'vancapticins'.

Main Results:

• Vancapticins demonstrated enhanced membrane affinity and potent activity against methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive bacteria.
• The modified antibiotics retained efficacy against glycopeptide-resistant bacterial strains.
• Optimized vancapticins showed significant in vivo efficacy in preclinical models of bacterial infection.

Conclusions:

• The membrane-targeting strategy successfully revitalized vancomycin, creating effective 'vancapticins'.
• This approach offers a promising method to combat recalcitrant bacterial infections.
• The strategy may also enhance the efficacy of other drugs targeting membrane-associated receptors.